The Mutation Generation and Detection Core (MGD) specializes in providing reagents for targeted genome editing. Services include knocking out specific genes, creating genes with limited or altered expression patterns, and tagging genes to express specific proteins sequence tags. Investigators can order custom TALEN and Crispr-Cas9 DNA nucleases to induce targeted mutations in a genomic region of interest. These targeted nucleases are a cutting edge technology for performing reverse genetic studies in multiple model systems, including, but not limited to, Zebrafish, Drosophila, C. elegans, mice and mammalian tissue culture. The Core continues to develop new technologies to offer investigators the most efficient reagents and methods possible. Through the Center for Iron and Heme Disorders (CIHD), investigators can be trained in the design, construction and delivery of the genome editing reagents. Additionally, the Core will assist users in designing strategies to analyze correct targeting and ensure that there are no off-target events. The staff will also offer CIHD-sponsored workshops/training sessions for junior investigators. This technology will also be made available to other national NIDDK-sponsored research programs. The primary goal of the MGD Core is to expand the use of these genome-editing technologies to NIH-funded investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54DK110858-01
Application #
9180277
Study Section
Special Emphasis Panel (ZDK1-GRB-R (M4)S)
Project Start
Project End
Budget Start
2016-08-05
Budget End
2017-07-31
Support Year
1
Fiscal Year
2016
Total Cost
$51,813
Indirect Cost
$17,509
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yien, Yvette Y; Shi, Jiahai; Chen, Caiyong et al. (2018) FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity. J Biol Chem 293:19797-19811
Choby, Jacob E; Buechi, Hanna B; Farrand, Allison J et al. (2018) Molecular Basis for the Evolution of Species-Specific Hemoglobin Capture by Staphylococcus aureus. MBio 9:
Chen, Brenden; Solis-Villa, Constanza; Erwin, Angelika L et al. (2018) Identification and characterization of 40 novel hydroxymethylbilane synthase mutations that cause acute intermittent porphyria. J Inherit Metab Dis :
Philpott, Caroline C (2018) The flux of iron through ferritin in erythrocyte development. Curr Opin Hematol 25:183-188
Yuan, Xiaojing; Hamza, Iqbal (2018) Cys Links Heme: Stereo-orientation of Heme Transfer in Cytochrome c Biogenesis. J Mol Biol 430:1081-1083
García-Guerrero, Aldo E; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angélica et al. (2018) Cbp3 and Cbp6 are dispensable for synthesis regulation of cytochrome b in yeast mitochondria. J Biol Chem 293:5585-5599
Schumann, Canan; Chan, Stephanie; Millar, Jess A et al. (2018) Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin. Nanomedicine 14:1395-1405
Akam, E A; Utterback, R D; Marcero, J R et al. (2018) Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production. J Inorg Biochem 180:186-193
Ryu, Moon-Suhn; Duck, Kari A; Philpott, Caroline C (2018) Ferritin iron regulators, PCBP1 and NCOA4, respond to cellular iron status in developing red cells. Blood Cells Mol Dis 69:75-81
Chen, Andy Jing; Yuan, Xiaojing; Li, Junjie et al. (2018) Label-Free Imaging of Heme Dynamics in Living Organisms by Transient Absorption Microscopy. Anal Chem 90:3395-3401

Showing the most recent 10 out of 48 publications